#WCE2014 – The use of exome genotyping to predict pathological Gleason score upgrade after radical prostatectomy in low-risk prostate cancer patients – Abstract | Prostate Cancer | UroToday

Abiraterone Acetate and Docetaxel, mcrpc, zytiga, advanced prostate cancer treatments, prostate cancer, GU oncology news, urology news, asco (#WCE2014 – The use of exome genotyping to predict pathological Gleason score upgrade after radical…

Source: urotoday.com

See on Scoop.itProstate Cancer: Psycho-Social Aspects to Disease Pathway Management